Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Viking Therapeutics
Biotech
Viking liver disease drug reduces fibrosis in final ph. 2 data
The drug reduced liver fat content by an average of 37% to 55%, with all treatment arms showing significant improvements compared to placebo.
Darren Incorvaia
Nov 20, 2024 3:20pm
Viking oral obesity med posts 6.8% weight loss for highest dose
Nov 4, 2024 7:30am
Viking to charge quickly into phase 3 with obesity med
Jul 25, 2024 9:19am
Pfizer's obesity pill news leaves analysts wanting
Jul 12, 2024 10:17am
Terns' ex-MASH drug cuts fat, not muscle in GLP-1 combo in mice
Jun 25, 2024 8:51am
Viking's MASH drug scores where Madrigal's didn't
Jun 4, 2024 1:51pm
